The Binding Site Group, Ltd. recalls FREELITE Human Kappa Free Kit for use on the Roche cobas c Systems, Kappa Freie Leichtkette (Human) kit for Roche cobas…
- Recall date
- May 20, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2030-2021
- FDA classification
- Class II
- Brand / firm
- The Binding Site Group, Ltd.
- Sold / distributed
- Worldwide distribution - US Nationwide distribution in the states of CA, GA, FL, MA, MO, MI, WA, NY, PA, MN, AL, MD, OK, NE, IN, ID, OH, TX, HI, DC and the countries of Canada, Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Italy, Luxembour…
Why it was recalled
The high and low level "Quality Controls" demonstrate a positive bias of approximately 10% compared to assigned values.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
FREELITE Human Kappa Free Kit for use on the Roche cobas c Systems, Kappa Freie Leichtkette (Human) kit for Roche cobas c Systems, REF: LK016.CB, IVD CE, UDI: 05051700012096
Get recall alerts
Free email alert whenever The Binding Site Group, Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: The Binding Site Group, Ltd.